Biliary tract cancer study: biomarkers and quality of life
Part of Cancer, Digestive system clinical trials.
This study is collecting information and blood samples from people with biliary tract cancer to understand how certain markers and quality-of-life measures relate to treatment outcomes. The findings may help improve future care and support.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with biliary tract cancer (cancer of the bile ducts, gallbladder, or the area where the bile ducts meet the intestine).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for new ways to measure cancer-related “biomarkers” (signals in blood or tumor samples) in people with bile duct cancer or gallbladder cancer. The goal is to improve how these cancers are identified and tracked, which could help doctors make better treatment decisions.
This study looks at tumor tissue samples from people with bile duct or gallbladder cancer to find biomarkers (clues in the tumor) that might help guide future treatment. By studying these samples, researchers hope to understand more about these cancers and improve care.
This study is testing a new blood test that looks for signs of DNA changes linked to biliary tract cancer. It aims to see if the test can find these cancers early. If you have biliary tract cancer or a high suspicion of it, you may be able to help.
This study looks at tissue samples from people with bile duct, liver, or pancreas problems to develop better ways to detect cancers in these areas. If you are scheduled for a biopsy, scan, or surgery for a suspected growth in your liver, pancreas, or bile duct, you may be able to help.
This study looks at whether a bile sample and a blood sample can show the same gene changes found in a tumor biopsy for people with bile duct or gallbladder cancer. It aims to see if these simpler tests could be used instead of a tumor tissue sample.
This trial uses a simple blood test to track how well bile duct cancer responds to treatment and to predict outcomes. It may help doctors make better decisions about surgery and other therapies.
Hear when a new Biliary Tract Cancer (CCA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.